Publications on People Who Inject Drugs (PWID)

This Guide for Advocacy is intended to be a user-friendly resource for people from all sectors who wish to understand the key objectives, principles and concepts relating to decriminalisation of drug use and how to advocate for it. Through three stages – Know it, Show it, Grow it – it outlines practical steps for developing strategies to advocate for decriminalisation, and offers tools that can be adapted and applied to plant the seeds for cultivating healthy, safe and inclusive communities.

This briefing provides an overview of the key questions that drug decriminalisation advocates should consider to mobilise for and demand reform.

This report is a compilation of data provided or published by countries in the region on their national situation relating to compulsory drug treatment and rehabilitation. It also serves as a mechanism for monitoring progress towards meeting commitments agreed by countries in 2015 in Manila to phase out compulsory treatment and rehabilitation and to scale up the implementation of voluntary community-based treatment and services.

Get an overview of the HIV/AIDS situation for People Who Inject Drugs (PWID) populations.

COVID-19, as well as government responses to the pandemic, are having unprecedented impacts on peoples’ lives, and are exacerbating vulnerabilities and inequalities. Since the early stages of the pandemic, many governments have resorted to securitised strategies centred around control and punishment, often leading to policies skewed towards repression and control, rather than health, transparency, and socio-economic support. Furthermore, the expansion of law enforcement powers has in several contexts resulted in increased criminalisation, surveillance, and targeting. As a result, populations already vulnerable and marginalised have experienced heightened policing, discrimination, and detrimental impacts on their rights and health. While the impacts of these policies on vulnerable communities such as women, migrant workers, and refugees are well-documented, less information is available on the repercussions on the rights and health of people who use drugs and their communities. This report presents and analyses the findings of research conducted with and among people who use drugs, service providers, and community paralegals in Indonesia and the Philippines, exploring how COVID-19 measures impacted on their livelihood, security, health, and human rights.

Consisting of five separate booklets, the World Drug Report 2021 provides an in-depth analysis of the global drug markets and paints a comprehensive picture of the measurable effects and potential impact of the COVID-19 crisis on the world drug problem. The World Drug Report 2021 is aimed not only at fostering greater international cooperation to counter the impact of the world drug problem on health, governance and security, but also, with its special focus on the impact of the COVID-19 pandemic, at assisting Member States in anticipating and addressing challenges that may arise in the near future.

The 2021-2026 Global AIDS Strategy has bold and critical new targets on realizing human rights, reducing stigma, discrimination and violence and removing harmful punitive laws as a pathway to ending inequalities and ultimately ending AIDS. To aid in the scale up of interventions to remove these societal barriers, UNAIDS has produced a series of fact sheets on human rights in various areas, highlighting the critical need to scale up action on rights. They are a series of short, easy to digest and accessible documents outlining the latest epidemiology, the evidence of the impact of human rights interventions, the latest targets, and international guidelines, recommendations and human rights obligations relating to each topic. Fact sheets released in June 2021: HIV criminalization, HIV and people who use drugs, HIV and gay men and who have sex with other men, HIV and transgender and other gender-diverse people, HIV and sex work, HIV and people in prisons and other closed settings and HIV and stigma and discrimination.

NCASC conducted a nation-wide descriptive cross-sectional survey among people who inject drugs (PWID) in all Provinces of Nepal to generate both national and subnational HIV estimates

This report explores the state of harm reduction funding in low- and middle-income countries, drawing upon existing public data on domestic funding and information collected from international harm reduction donors. The data shows that we are further away from meeting the needs of people who use drugs than ever before.

On 11 March 2020, the World Health Organization declared COVID-19 a pandemic. Since then, the virus has claimed millions of lives and has transformed nearly every aspect of our individual and collective reality. As with all areas of life, drug consumption, related harms and drug markets have been impacted, as have the services established to respond to drug-related problems. During the first weeks of the pandemic, the EMCDDA instigated two rapid assessment studies to identify the initial impact and implications of COVID-19. These studies identified signs of an overall decline in some forms of drug use during the first 3 months of the pandemic, largely as a result of national confinement measures. In addition, many drug services were forced to close or restrict their access, new measures for hygiene and social distancing were implemented, and there was a shift towards greater use of telemedicine.